Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Open-label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)

NCT06371417 is registered in ClinicalTrials.gov with Chugai Pharmaceutical as lead sponsor.

NCT NCT06371417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Open-label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)
Lead sponsor
Chugai Pharmaceutical
Phase
Phase 1
Overall status
Recruiting
Start date
August 19, 2024
Completion date
June 30, 2027
Enrollment
144 (estimated)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome (aps), behçet's syndrome (bs), bullous pemphigoid (bp), dermatomyositis (dm), immune thrombocytopenia (itp), immune-mediated necrotizing myopathy (imnm)